Multimillion-dollar manufacturing outlays are becoming an annual tradition at Sandoz’s antibiotics plant in Kundl, Austria. After similar moves in 2020 and 2021, Novartis’ generics arm on Monday said ...
(Reuters) -Sandoz, the generic drugs business that will be spun off its parent Novartis, will boost investment in its European antibiotics production network by 50 million euros ($50 million) on ...
Chances are your hamburger is on drugs. Not the illegal kind—probably—but the medicinal sort. Though the statistics are fuzzy, environmentalists and sustainable food advocates believes vast amounts of ...
The US Food and Drug Administration (FDA) warned Turkish drugmaker Deva Holding AS earlier this month over good manufacturing practice (GMP) violations at the company’s Tekirdağ manufacturing site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results